A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
Clinical trial NCT03986944 · TERMINATED
Trial details
- NCT number
- NCT03986944
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2021-01-06
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.